Immunotherapy in inflammatory bowel disease.
D000328:Adult; D000477:Alkylating Agents / Q000627:therapeutic use; D000963:Antimetabolites / Q000627:therapeutic use; D001379:Azathioprine / Q000627:therapeutic use; D002648:Child; D002986:Clinical Trials as Topic; D003093:Colitis, Ulcerative / Q000188:drug therapy*; D003424:Crohn Disease / Q000188:drug therapy*; D004205:Cromolyn Sodium / Q000627:therapeutic use; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D008297:Male; D015122:Mercaptopurine / Q000627:therapeutic use; D008795:Metronidazole / Q000627:therapeutic use
D000477:Alkylating Agents; D000963:Antimetabolites; D007166:Immunosuppressive Agents; D008795:Metronidazole; D015122:Mercaptopurine; D001379:Azathioprine; D004205:Cromolyn Sodium